Independent.ie on MSN6d
Clinical trials giant Icon Plc warns investors delay to its Covid vaccine study will hit its revenue for first half of 2025Icon PLC, the Irish-headquartered clinical research giant, has warned the markets that a large Covid-19 vaccine study it recently told investors about was delayed by its sponsor. In February, CEO ...
Will use Mural Link’s functionality related to clinical trial participant support services, communication tools, and ...
Interim Results from clinical study for cutaneous carcinomas presented at Late-Breaking Research SessionMarlborough, Massachusetts--(Newsfile ...
Icon (ICLR) and Mural Health, a clinical trial technology company, announced a partnership to utilize Mural’s participant management and ...
Icon Plc, a Dublin-headquartered clinical researcher for pharmaceutical firms, is facing a potential US court battle over claims it issued misleading statements and caused “substantial losses ...
Tears represent a clinical entity for some tendons which is distinct from tendinopathy, and which may require different management to that of tendinopathy. The ICON group defined tears as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback